Terms: = Uterine cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Clinical Outcome
23 results:
1. clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma.
Madariaga A; Garg S; Tchrakian N; Dhani NC; Jimenez W; Welch S; MacKay H; Ethier JL; Gilbert L; Li X; Rodriguez A; Chan L; Bowering V; Clarke B; Zhang T; King I; Downs G; Stockley T; Wang L; Udagani S; Oza AM; Lheureux S
Nat Commun; 2023 Mar; 14(1):1452. PubMed ID: 36922497
[TBL] [Abstract] [Full Text] [Related]
2. clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma.
Kobayashi Kato M; Asami Y; Takayanagi D; Matsuda M; Shimada Y; Hiranuma K; Kuno I; Komatsu M; Hamamoto R; Matsumoto K; Ishikawa M; Kohno T; Kato T; Shiraishi K; Yoshida H
Cancer Sci; 2022 May; 113(5):1712-1721. PubMed ID: 35278272
[TBL] [Abstract] [Full Text] [Related]
3. Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome.
Hollis RL; Thomson JP; Stanley B; Churchman M; Meynert AM; Rye T; Bartos C; Iida Y; Croy I; Mackean M; Nussey F; Okamoto A; Semple CA; Gourley C; Herrington CS
Nat Commun; 2020 Oct; 11(1):4995. PubMed ID: 33020491
[TBL] [Abstract] [Full Text] [Related]
4. Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the uterine Corpus are Characterized by CTNNB1 Mutations and Can Show Adverse clinical outcomes.
Ladwig NR; Umetsu SE; Zaloudek C; Rabban J; Garg K
Int J Gynecol Pathol; 2021 Mar; 40(2):103-115. PubMed ID: 32909971
[TBL] [Abstract] [Full Text] [Related]
5. Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer.
Polychronidou G; Kotoula V; Manousou K; Kostopoulos I; Karayannopoulou G; Vrettou E; Bobos M; Raptou G; Efstratiou I; Dionysopoulos D; Chatzopoulos K; Lakis S; Chrisafi S; Tsolakidis D; Papanikolaou A; Dombros N; Fountzilas G
PLoS One; 2018; 13(12):e0208221. PubMed ID: 30521558
[TBL] [Abstract] [Full Text] [Related]
6. Identification of CD28 and pten as novel prognostic markers for cervical cancer.
Shen F; Zheng H; Zhou L; Li W; Liu J; Xu X
J Cell Physiol; 2019 May; 234(5):7004-7011. PubMed ID: 30362552
[TBL] [Abstract] [Full Text] [Related]
7. DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation.
Bean GR; Anderson J; Sangoi AR; Krings G; Garg K
Mod Pathol; 2019 Feb; 32(2):280-289. PubMed ID: 30266945
[TBL] [Abstract] [Full Text] [Related]
8. Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas.
Coenegrachts L; Garcia-Dios DA; Depreeuw J; Santacana M; Gatius S; Zikan M; Moerman P; Verbist L; Lambrechts D; Matias-Guiu X; Amant F
Virchows Arch; 2015 Apr; 466(4):415-22. PubMed ID: 25677978
[TBL] [Abstract] [Full Text] [Related]
9. outcomes of patients with metastatic cervical cancer in a phase I clinical trials program.
Hou MM; Liu X; Wheler J; Naing A; Hong D; Bodurka D; Schmeler K; Tsimberidou A; Janku F; Zinner R; Piha-Paul S; Hu CY; Lu K; Kurzrock R; Fu S
Anticancer Res; 2014 May; 34(5):2349-55. PubMed ID: 24778042
[TBL] [Abstract] [Full Text] [Related]
10. clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma.
Li M; Zhao L; Shen D; Li X; Wang J; Wei L
Chin Med J (Engl); 2014; 127(8):1459-63. PubMed ID: 24762589
[TBL] [Abstract] [Full Text] [Related]
11. Primary squamous cell carcinoma of the endometrium: clinicopathologic and molecular characteristics.
Bures N; Nelson G; Duan Q; Magliocco A; Demetrick D; Duggan MA
Int J Gynecol Pathol; 2013 Nov; 32(6):566-75. PubMed ID: 24071873
[TBL] [Abstract] [Full Text] [Related]
12. Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma.
Zhou J; Roh JW; Bandyopadhyay S; Chen Z; Munkarah AR; Hussein Y; Alosh B; Jazaerly T; Hayek K; Semaan A; Sood AK; Ali-Fehmi R
Gynecol Oncol; 2013 Feb; 128(2):344-8. PubMed ID: 22871469
[TBL] [Abstract] [Full Text] [Related]
13. Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC clinical Trials Group.
Oza AM; Elit L; Tsao MS; Kamel-Reid S; Biagi J; Provencher DM; Gotlieb WH; Hoskins PJ; Ghatage P; Tonkin KS; Mackay HJ; Mazurka J; Sederias J; Ivy P; Dancey JE; Eisenhauer EA
J Clin Oncol; 2011 Aug; 29(24):3278-85. PubMed ID: 21788564
[TBL] [Abstract] [Full Text] [Related]
14. PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer.
Urick ME; Rudd ML; Godwin AK; Sgroi D; Merino M; Bell DW
Cancer Res; 2011 Jun; 71(12):4061-7. PubMed ID: 21478295
[TBL] [Abstract] [Full Text] [Related]
15. [Evaluation of risk of progression of endometrial hyperplasia in patients with metabolic syndrome].
Bochkareva NV; Kolomiets LA; Chernyshova AL; Stukanov SL; Savenkova OV
Vopr Onkol; 2010; 56(5):617-22. PubMed ID: 21137246
[TBL] [Abstract] [Full Text] [Related]
16. Tissue and serum biomarkers as prognostic variables in endometrioid-type endometrial cancer.
Gadducci A; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2011 Nov; 80(2):181-92. PubMed ID: 21134766
[TBL] [Abstract] [Full Text] [Related]
17. Combined pten and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas.
Dellas A; Jundt G; Sartorius G; Schneider M; Moch H
Clin Cancer Res; 2009 Apr; 15(7):2456-62. PubMed ID: 19293259
[TBL] [Abstract] [Full Text] [Related]
18. Squamous morules are functionally inert elements of premalignant endometrial neoplasia.
Lin MC; Lomo L; Baak JP; Eng C; Ince TA; Crum CP; Mutter GL
Mod Pathol; 2009 Feb; 22(2):167-74. PubMed ID: 19180120
[TBL] [Abstract] [Full Text] [Related]
19. Novel molecular profiles of endometrial cancer-new light through old windows.
Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438
[TBL] [Abstract] [Full Text] [Related]
20. Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors.
Abal M; Planaguma J; Gil-Moreno A; Monge M; Gonzalez M; Baro T; Garcia A; Castellvi J; Ramon Y Cajal S; Xercavins J; Alameda F; Reventos J
Histol Histopathol; 2006 Feb; 21(2):197-204. PubMed ID: 16329044
[TBL] [Abstract] [Full Text] [Related]
[Next]
